IceCure Medical Ltd. Ordinary Shares — Rendiconto Finanziario Trimestrale (NASDAQ:ICCM) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Market Capitalization 25.59 M
Employee 66
Founded N/A
CEO Eyal Shamir
Website www.icecure-medical.com
Headquarter Israel
FIGI UNKNOWN
Industry Technology

Ricavi totali

Utile netto

Debito totale

Liquidità libera

Disponibilità liquide e mezzi equivalenti

25.59 M Capitalizzazione di mercato

Notizie

IceCure Medical Ltd (ICCM) Q4 2025 Earnings Call Transcript

IceCure Medical convoca assemblea straordinaria degli azionisti per gennaio 2026

IceCure Medical schedules special shareholder meeting for January 2026

Nvidia, Target, TJX, and more set to report earnings Wednesday

Viatris (VTRS) Beats Q3 Earnings and Revenue Estimates

Acadia Healthcare (ACHC) Beats Q3 Earnings and Revenue Estimates

Le azioni di IceCure Medical salgono dopo studio sulla crioablazione che mostra tassi di sopravvivenza migliorati

IceCure Medical stock jumps after cryoablation study shows improved survival rates

Freezing Cancer With IceCure: ProSense Cryoablation System Receives FDA Marketing Authorization For Early-Stage Breast Cancer Treatment - Icecure Medical (NASDAQ:ICCM)

Obiettivo di prezzo di IceCure Medical alzato a $2,50 da $2,00 da H.C. Wainwright

IceCure Medical stock price target raised to $2.50 from $2.00 at H.C. Wainwright

IceCure Medical Ltd (ICCM) U.S. FD&A's MarketingAuthorizationforProSenseCryoablation Call